Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IL › MELROSE PARK › UCKERMAN, MARY

UCKERMAN, MARY

NPI: 1801809322 · MELROSE PARK, IL 60160 · Clinical Pathology/Laboratory Medicine Physician · NPI assigned 08/14/2006

$4.20M
Total Medicaid Paid
614,498
Total Claims
453,120
Beneficiaries
180
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 284 $4K
2019 93,742 $481K
2020 79,879 $370K
2021 78,738 $647K
2022 136,926 $1.17M
2023 115,359 $856K
2024 109,570 $676K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 12,029 10,244 $458K
80053 Comprehensive metabolic panel 51,947 34,965 $262K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,678 3,066 $242K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 4,845 4,603 $228K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 73,516 43,981 $210K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8,827 8,403 $191K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8,793 8,383 $190K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,071 6,930 $187K
83735 37,312 17,693 $126K
80048 Basic metabolic panel (calcium, ionized) 28,097 14,911 $114K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,489 1,450 $108K
84484 18,799 14,762 $96K
82805 3,986 2,496 $90K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,725 5,342 $86K
83880 7,991 6,699 $85K
84443 Thyroid stimulating hormone (TSH) 9,544 8,777 $77K
87040 6,171 4,852 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,229 1,901 $65K
87086 Culture, bacterial; quantitative colony count, urine 12,389 11,206 $62K
88307 872 754 $58K
86850 7,319 6,349 $58K
82962 27,785 10,199 $47K
83605 8,078 5,928 $44K
83690 12,919 11,185 $43K
85730 8,617 6,387 $28K
87081 9,975 9,447 $28K
87480 2,038 1,994 $26K
87510 2,008 1,966 $26K
86901 11,612 10,333 $25K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,207 1,182 $25K
86803 3,157 2,978 $25K
84100 13,159 5,381 $25K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,104 997 $24K
85027 8,632 5,531 $24K
81003 22,980 20,441 $24K
80061 Lipid panel 5,970 5,628 $21K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,768 2,586 $21K
87186 3,623 3,242 $21K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,351 2,218 $20K
84702 4,313 3,481 $20K
86900 11,615 10,337 $19K
82803 1,952 1,597 $19K
85610 9,673 6,489 $19K
87660 2,217 2,153 $18K
83036 Hemoglobin; glycosylated (A1C) 5,790 5,355 $18K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 696 684 $17K
87340 2,673 2,527 $17K
85379 4,403 3,495 $16K
87641 809 731 $16K
82607 2,715 2,538 $16K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 101 98 $16K
88342 865 779 $16K
83021 2,437 2,161 $15K
82261 1,829 1,592 $15K
83498 1,925 1,686 $14K
80202 1,910 996 $13K
80076 4,214 3,620 $13K
82728 3,047 2,356 $12K
82746 2,124 1,979 $12K
82542 1,569 1,374 $11K
82550 4,882 3,553 $11K
83789 1,482 1,293 $10K
84466 2,320 2,135 $10K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 693 672 $10K
84145 1,401 1,107 $10K
86140 3,802 2,868 $9K
81514 219 216 $8K
82553 2,485 2,185 $8K
84439 1,881 1,687 $8K
83516 1,631 1,437 $8K
80081 259 238 $8K
82247 3,329 1,873 $8K
83540 2,350 2,162 $7K
82077 664 617 $7K
82248 3,561 2,094 $7K
86920 1,722 1,404 $7K
87210 3,144 2,960 $7K
82570 3,054 2,610 $7K
86356 478 423 $7K
87147 2,353 2,116 $7K
86592 3,217 3,066 $6K
86880 2,194 2,072 $6K
86762 1,317 1,257 $6K
83615 2,328 1,496 $6K
87070 1,757 1,435 $5K
82776 1,507 1,319 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 159 130 $5K
81001 3,885 3,465 $5K
83970 286 257 $4K
82150 1,272 1,149 $4K
81025 1,515 1,328 $4K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 101 99 $4K
86780 476 468 $4K
87807 690 668 $3K
82565 1,640 1,319 $3K
80074 177 140 $3K
84550 1,790 1,479 $3K
85652 2,407 2,178 $3K
87075 522 436 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 139 130 $3K
86038 369 350 $3K
87205 1,387 1,136 $3K
84156 2,300 1,917 $3K
82950 1,076 1,039 $2K
86706 362 356 $2K
87486 101 98 $2K
86787 316 298 $2K
88313 93 86 $2K
87581 101 98 $2K
83919 269 230 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 124 103 $2K
87449 137 120 $2K
86480 65 65 $2K
82375 671 335 $1K
87493 62 59 $1K
83001 148 147 $1K
82105 164 161 $1K
84403 101 99 $1K
85018 1,160 906 $1K
85014 1,072 848 $1K
87529 26 25 $1K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 26 25 $1K
82009 794 715 $962.66
84146 138 133 $959.62
82140 244 155 $956.37
82043 448 434 $877.65
85384 292 215 $851.97
84300 391 313 $835.20
82330 118 75 $821.64
86235 14 13 $767.00
82128 315 266 $765.00
82760 326 277 $729.29
88341 27 24 $727.65
85045 570 455 $718.52
80179 55 52 $682.18
80143 55 52 $682.18
86885 238 225 $680.15
88112 29 27 $664.34
82016 253 213 $606.90
87077 185 141 $576.18
87088 95 88 $493.00
86225 72 70 $424.80
84478 256 106 $413.61
80069 102 29 $393.13
86160 42 42 $392.72
80055 27 25 $377.04
82670 37 37 $322.94
83930 124 112 $316.88
84703 90 86 $304.30
87150 16 13 $270.00
84132 185 139 $252.66
85060 25 24 $247.89
86870 31 26 $222.27
80164 49 24 $212.64
82784 16 13 $208.84
88141 16 16 $202.13
81015 138 131 $180.78
80050 General health panel 592 528 $170.40
86431 46 45 $151.45
84144 19 12 $150.24
G0103 Prostate cancer screening; prostate specific antigen test (psa) 15 15 $129.36
82533 18 16 $118.77
83020 24 24 $99.13
86593 47 43 $94.00
84425 13 13 $92.12
83002 15 15 $83.40
86704 14 14 $83.21
86200 15 15 $78.50
88312 13 12 $64.64
82785 13 13 $63.37
86376 13 13 $56.80
85520 18 17 $53.55
80305 12 12 $49.39
83935 14 12 $32.62
84165 14 14 $31.50
84450 12 12 $26.20
84460 12 12 $25.90
89050 12 12 $24.50
84520 13 13 $21.23
82272 13 12 $16.51